Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cerner, Claritas Genomics Partner to Develop Cloud-based LIMS for NGS Testing

Published: Tuesday, December 17, 2013
Last Updated: Monday, December 16, 2013
Bookmark and Share
Partnership focused on building tools that will help clinical laboratories advance next-generation sequencing-based testing

Healthcare technology vendor Cerner and Claritas Genomics, a genetic diagnostic testing company, have announced a partnership focused on building tools that will help clinical laboratories advance next-generation sequencing-based testing into the traditional molecular diagnostic setting.

Specifically, the partners plan to develop and launch in the next two years a cloud-based laboratory information management system (LIMS) that can handle the data processing and analysis steps required for NGS-based workflows, according to Maki Moussavi, Cerner's senior practice manager for genomic solutions.

The LIMS will enable users to integrate the instruments and analysis software that they use as part of their sequencing workflows and help them move sequence data across these systems.

Separately, Claritas is implementing Millenium Helix, Cerner's laboratory information system for capturing data from traditional molecular diagnostics activities such as SNP testing and cytogenetics as part of its collaboration with the healthcare technology firm. It will use the solution for its non-NGS-based testing activities in addition to helping Cerner develop its new cloud solution, Moussavi said.

The partners plan to begin testing an early version of the new LIMS at Claritas in 2014, ahead of the full commercial release planned for the following year.

As part of the relationship, Cerner Capital, a wholly-owned subsidiary of Cerner, has invested in Claritas, becoming a minority shareholder and bringing to a close the company's Series A round. Also, Clay Patterson, managing director of Cerner Capital, now sits on Claritas' board of directors. In addition, Claritas will join Cerner's Reference Lab Network, which provides a single interface for ordering tests and returning results.

Meanwhile, Cerner's considering adding new partners to its LIMS development program. According to Moussavi, a number of Helix customers have indicated their interest in branching out into the NGS-based testing arena and the company is currently sorting through potential partnerships.

"We will be forming what we call an advisory board of clients," she said. It will basically be "a small tight group of clients who have some experience in [NGS] to make sure that any development that we do is not specifically tailored to a particular site but takes into consideration all the different workflows and use cases."

Claritas, for instance, focuses more on pediatric testing "but we will have other clients who are focused on oncology and other areas and we want to make sure that we are not developing to a particular specialty," she added. Furthermore, although Cerner is targeting clinical testing laboratories, the LIMS software will also be flexible enough for research use, Moussavi said.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Apricot Kernels Pose Risk of Cyanide Poisoning
Eating more than three small raw apricot kernels, or less than half of one large kernel, in a serving can exceed safe levels. Toddlers consuming even one small apricot kernel risk being over the safe level.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Genetic Markers Influence Addiction
Differences in vulnerability to cocaine addiction and relapse linked to both inherited traits and epigenetics, U-M researchers find.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
A lncRNA Regulates Repair of DNA Breaks in Breast Cancer Cells
Findings give "new insight" into biology of tough-to-treat breast cancer.
COPD Linked to Increased Bacterial Invasion
Persistent inflammation in COPD may result from a defect in the immune system that allows airway bacteria to invade deeper into the lung.
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!